company background image
7774 logo

Japan Tissue Engineering TSE:7774 Stock Report

Last Price

JP¥471.00

Market Cap

JP¥19.0b

7D

4.0%

1Y

-3.3%

Updated

12 Feb, 2025

Data

Company Financials +

Japan Tissue Engineering Co., Ltd.

TSE:7774 Stock Report

Market Cap: JP¥19.0b

7774 Stock Overview

Engages in the regenerative medicine business in Japan. More details

7774 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 58.3% below our estimate of its fair value

Earnings are forecast to grow 53.24% per year

Earnings have grown 9.9% per year over the past 5 years

Risk Analysis

No risks detected for 7774 from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Japan Tissue Engineering Co., Ltd. Competitors

ReproCELL

TSE:4978

JP¥18.8b

Pharma Foods International

TSE:2929

JP¥26.6b

Heartseed

TSE:219A

JP¥36.0b

Kohjin Bio

TSE:177A

JP¥8.1b

Price History & Performance

Summary of share price highs, lows and changes for Japan Tissue Engineering
Historical stock prices
Current Share PriceJP¥471.00
52 Week HighJP¥811.00
52 Week LowJP¥430.00
Beta0
1 Month Change-0.42%
3 Month Change-4.66%
1 Year Change-3.29%
3 Year Change-5.42%
5 Year Change-44.52%
Change since IPO19.54%

Recent News & Updates

Little Excitement Around Japan Tissue Engineering Co., Ltd.'s (TSE:7774) Revenues

Aug 01
Little Excitement Around Japan Tissue Engineering Co., Ltd.'s (TSE:7774) Revenues

Recent updates

Little Excitement Around Japan Tissue Engineering Co., Ltd.'s (TSE:7774) Revenues

Aug 01
Little Excitement Around Japan Tissue Engineering Co., Ltd.'s (TSE:7774) Revenues

The Market Lifts Japan Tissue Engineering Co., Ltd. (TSE:7774) Shares 35% But It Can Do More

Mar 06
The Market Lifts Japan Tissue Engineering Co., Ltd. (TSE:7774) Shares 35% But It Can Do More

We Think Japan Tissue Engineering (TYO:7774) Can Afford To Drive Business Growth

Feb 02
We Think Japan Tissue Engineering (TYO:7774) Can Afford To Drive Business Growth

Shareholder Returns

7774JP BiotechsJP Market
7D4.0%6.0%0.007%
1Y-3.3%21.9%3.6%

Return vs Industry: 7774 underperformed the JP Biotechs industry which returned 21.9% over the past year.

Return vs Market: 7774 underperformed the JP Market which returned 3.6% over the past year.

Price Volatility

Is 7774's price volatile compared to industry and market?
7774 volatility
7774 Average Weekly Movement3.1%
Biotechs Industry Average Movement8.8%
Market Average Movement3.5%
10% most volatile stocks in JP Market7.5%
10% least volatile stocks in JP Market1.8%

Stable Share Price: 7774 has not had significant price volatility in the past 3 months compared to the JP market.

Volatility Over Time: 7774's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1999211Ken-Ichiro Hatawww.jpte.co.jp

Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment.

Japan Tissue Engineering Co., Ltd. Fundamentals Summary

How do Japan Tissue Engineering's earnings and revenue compare to its market cap?
7774 fundamental statistics
Market capJP¥18.96b
Earnings (TTM)-JP¥153.47m
Revenue (TTM)JP¥2.43b

7.9x

P/S Ratio

-124.6x

P/E Ratio

Is 7774 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7774 income statement (TTM)
RevenueJP¥2.43b
Cost of RevenueJP¥922.61m
Gross ProfitJP¥1.51b
Other ExpensesJP¥1.67b
Earnings-JP¥153.47m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-3.78
Gross Margin62.11%
Net Profit Margin-6.30%
Debt/Equity Ratio0%

How did 7774 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/12 08:27
End of Day Share Price 2025/02/12 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Japan Tissue Engineering Co., Ltd. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hidemaru YamaguchiCitigroup Inc
Kiyokazu YamazakiIchiyoshi Research Institute Inc.
Shigekazu IshidaMarusan Securities Co. Ltd.